PRODUCT

Tesofensine

No short description available.

Research Indications

Weight Loss

moderate

Significant Weight Reduction
Phase 2/3 trials show 9-12% weight loss over 24 weeks, superior to many approved medications
Appetite Suppression
Potent central appetite suppression through triple monoamine mechanism
Metabolic Improvements
Improvements in triglycerides, insulin, and visceral fat in clinical trials

Metabolic

effective

Increased Energy Expenditure
May boost resting metabolic rate through noradrenergic effects
Lipid Improvements
Reductions in VLDL cholesterol and triglycerides observed

Interactions

SSRIs (Prozac, Zoloft, etc.)

Avoid Combination

High risk of serotonin syndrome due to overlapping serotonergic activity. Both increase serotonin levels which can lead to dangerous accumulation.

SNRIs (Effexor, Cymbalta, etc.)

Avoid Combination

Risk of serotonin syndrome and excessive norepinephrine stimulation. Combination may cause severe hypertension and cardiac effects.

MAOIs

Contraindicated

Absolutely contraindicated. Combination can cause life-threatening serotonin syndrome, hypertensive crisis, and death.

Stimulants (Adderall, Ritalin)

Avoid Combination

Overlapping dopaminergic and noradrenergic effects may cause severe cardiovascular stress, hypertension, and increased abuse potential.

Bupropion (Wellbutrin)

Avoid Combination

Both affect dopamine and norepinephrine reuptake. Combination increases risk of seizures, hypertension, and cardiac effects.

Semaglutide/Tirzepatide

Insufficient Data

No clinical data on combination. Different mechanisms (GLP-1 vs monoamine) but combined use is not recommended without medical supervision.

Beta-Blockers (Metoprolol)

Potentially Beneficial

Metoprolol may counteract tesofensine-induced heart rate and blood pressure increases while preserving appetite suppression. Studied in preclinical models.

Caffeine

Use Caution

May enhance stimulant-like effects and cardiovascular stress. Consider reducing caffeine intake while using tesofensine.

Tesofensine

Resources

Categories

Company